美国免除药品对印度进口品的关税,增加药剂库存。 US exempts pharmaceuticals from tariffs on Indian imports, boosting pharma stocks.

美国总统唐纳德·特朗普(Donald Trump)政府免除了医药产品新的对等关税,导致印度药剂库存猛增。 US President Donald Trump's administration has exempted pharmaceutical products from new reciprocal tariffs, leading to a surge in Indian pharma stocks. Aurobindo Pharma、Reddy博士和Sun Pharma等公司由于美国是它们出口的主要市场而大获成功。 Companies like Aurobindo Pharma, Dr. Reddy's, and Sun Pharma gained significantly as the US is a major market for their exports. 这一豁免被视为该行业的一个积极举措,该行业向美国供应45%以上的非专利药物。 This exemption is seen as a positive move for the industry, which supplies over 45% of generic drugs to the US. 然而,由于对印度其他进口品征收26%的关税,更广泛的市场面临波动性。 However, broader markets faced volatility due to the 26% tariffs imposed on other Indian imports.